Broadly, the results from the present study complement findings from previous studies and provide further support to the hypothesis that natural endocannabinoids, medical cannabis (marijuana), and synthetic ligands of CB1/2 alleviate pain in cancer patients and rodents bearing tumours. The gene discussed is CNR1; the disease is cancer.